Deep-Seq: Resistance to anti-EGFR therapy in colorectal cancer
In this study we performed ultra deep sequencing of genes associated with anti-EGFR resistance, such as KRAS, BRAF, PIK3CA, and EGFR in 17 plasma-DNA samples from a total of 10 patients treated with anti-EGFR therapy.
- Technology: Illumina MiSeq
- 25 samples
- DAC: EGAC00001000072
- Data Use Conditions:
- DS DUO:0000007 (version: 2019-01-07) disease specific research This data use permission indicates that use is allowed provided it is related to the specified disease. Modifiers MONDO:0005575
Studies are experimental investigations of a particular phenomenon. e.g. case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients. Click on one of the Study IDs below to find out more.
|Study ID||Study Title||Study Type|